These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9324787)

  • 1. [The anti-ischemic effect of angiotensin-converting enzyme inhibitors in treating stable stenocardia of effort in middle-aged and elderly patients].
    Lazebnik LB; Vertkin AL; Drozdova SL; Konev IuV; Goncharov LF
    Ter Arkh; 1996; 68(4):40-2. PubMed ID: 9324787
    [No Abstract]   [Full Text] [Related]  

  • 2. [The efficacy of Capoten in different clinical courses of acute myocardial infarct].
    Mikashinovich ZI; Terent'ev VP; Shlyk SV; Suroedova RA; Shepelev AA
    Anesteziol Reanimatol; 1996; (5):39-44. PubMed ID: 9027252
    [No Abstract]   [Full Text] [Related]  

  • 3. [The anti-ischemic effects of ACE inhibitors after an acute myocardial infarct].
    Rutherford JD
    Rev Clin Esp; 1996 Dec; 196(4 Monografico):41-2. PubMed ID: 9139332
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action?
    Rutherford JD
    Trans Am Clin Climatol Assoc; 1996; 107():57-66; discussion 66-7. PubMed ID: 8725560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative effectiveness of propranolol, nifedipine and their combination in exertion stenocardia patients].
    Romakov AIu; Sagirov AM; Sumarokov AB; Mazur NA
    Klin Med (Mosk); 1984 Mar; 62(3):71-5. PubMed ID: 6716933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Angiotensin-converting enzyme inhibition and angina pectoris].
    Odenthal HJ; Josephs W
    Dtsch Med Wochenschr; 1992 Nov; 117(48):1849-53. PubMed ID: 1451651
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of angiotensin-converting enzyme inhibitors in patients with ischemic heart disease].
    Martsevich SIu; Metelitsa VI; Vakulovskaia MK; Kozyreva MP
    Kardiologiia; 1993; 33(3):58-60. PubMed ID: 8377343
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
    Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV
    Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].
    Landmark K; Aursnes I
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1923-6. PubMed ID: 11488184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
    Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
    Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
    Edwards RJ; Redwood SR; Lambiase PD; Marber MS
    Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
    Dunaev VV; Kraĭdashenko OV; Berezin AE
    Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antioxidant protection of the heart by coenzyme Q10 in stable stenocardia of effort].
    Kogan AKh; Syrkin AL; Drinitsina SV; Kokanova IV
    Patol Fiziol Eksp Ter; 1999; (4):16-9. PubMed ID: 10598457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Control of myocardial ischemia in patients with effort angina and polyvascular atherosclerotic involvement].
    Saiutina EV; Chigineva VV; Zolozova EA; Karlova NA; Karlov AA; Pshenitsin AI; Mazur NA
    Kardiologiia; 2012; 52(8):15-9. PubMed ID: 23098393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.
    Solomon SD; Anavekar NS; Greaves S; Rouleau JL; Hennekens C; Pfeffer MA;
    J Am Coll Cardiol; 2004 May; 43(9):1511-4. PubMed ID: 15120803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of helium-neon laser irradiation on myocardial and thyroid functions in patients with ischemic heart disease].
    Ruzov VI; Rubanova MP; Grigor'ev MIu; Cherkunov KV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (5):7-9. PubMed ID: 9446315
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pharmacokinetic interaction of propranolol and nifedipine in patients with angina of effort].
    Kukushkin SK; Rumiantsev DO; Belolipetskaia VG; Kokurina EV; Piotrovskiĭ VK; Metelitsa VI
    Eksp Klin Farmakol; 1994; 57(1):32-5. PubMed ID: 8142860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors in angina and myocardial infarction. What role will they play in the 1990s?
    Ertl G
    Drugs; 1993 Aug; 46(2):209-18. PubMed ID: 7691512
    [No Abstract]   [Full Text] [Related]  

  • 20. [The possibilities for the pathogenetic therapy of ischemic heart disease under cardioselective loading].
    Ardashev VN; Smirnov AV; Ryndin AA; Shcherbak IuA
    Voen Med Zh; 1994 Jul; (7):29-31, 79. PubMed ID: 7810109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.